Active

QBIC Brussels Fund

Switched

BE0846785551

Rechtspersoon Public limited company 1 establishment

Witte Patersstraat 4, 1040 Etterbeek

Active for

14 year, 2 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.

Gross margin

€ -11,963

▲ 9% vs 2024

Profit

Caution

€ -13,560

▲ 95% vs 2024

Debts

Low

€ 30,329

▼ 14% vs 2024

QBIC Brussels Fund from Etterbeek, company number BE0846785551, closed financial year 2025 with a result of € -13,560 after tax. For that financial year QBIC Brussels Fund recorded a gross margin of € -11,963 and equity of € 2.1 million. Compared with financial year 2024, the result moved from € -300,669 to € -13,560. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.

What happened at QBIC Brussels Fund?

What happened at QBIC Brussels Fund in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Qbic Venture Partners BV stepped down as director. NBB
  • Jan Cornelis stepped down as director. NBB
  • Finance&invest.brussels NV stepped down as director. NBB
  • ING België NV stepped down as director. NBB
  • Yannik Hallet stepped down as director. NBB
  • Isabelle Cardinael stepped down as director. NBB
  • BNP Paribas Fortis Private Equity Belgium NV stepped down as director. NBB
  • Jean-Pierre Timmermans stepped down as director. NBB

In short

From € 141,350 loss in 2021 to € 13,560 loss in 2025.

Best year ever: 2023, with € 194,116 profit.

A new publication or filing at QBIC Brussels Fund? We notify you, reason included.

Follow QBIC Brussels Fund

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

QBIC Brussels Fund

It owns 5.5% of Ubidata and 2.7% of Confo Therapeutics itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Qbic Venture Partners BV

Managing director · represented by Zabeau Marc

Also active at: Morrow, OVIZIO IMAGING SYSTEMS, QBIC Feeder Fund +2 more

since 2024 · until 2026

Jan Cornelis

Director

Also active at: QBIC Feeder Fund, QBIC Arkiv Fund

since 2024 · until 2026

since 2024 · until 2026

since 2024 · until 2026

Yannik Hallet

Director

since 2024 · until 2026

Isabelle Cardinael

Director

Also active at: GEMMA FRISIUS-FONDS KU LEUVEN, Zeopore Technologies, QBIC Feeder Fund +1 more

since 2024 · until 2026

BNP Paribas Fortis Private Equity Belgium NV

Director · represented by Patricia Terryn

Also active at: HET ANKER, Anima Research, STUDIO 100 +4 more

since 2024 · until 2026

Jean-Pierre Timmermans

Director

Also active at: QBIC Feeder Fund, QBIC Arkiv Fund

since 2024 · until 2026

Herman Verwilst

Director

Also active at: QBIC Feeder Fund

since 2024 · until 2026

Steven Coppens

Director

Also active at: QBIC Feeder Fund, QBIC Arkiv Fund

since 2024 · until 2026

Rik Van De Walle

Director

since 2024 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Witte Patersstraat 4

1040 Etterbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 75 companies are registered at this address.

+70 more

Details

Company number
0846.785.551
VAT number
BE 0846.785.551
Registered office
Witte Patersstraat 4, 1040 Etterbeek
Names & denominations
QBIC Brussels Fund
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
22 June 2012
Peppol
Active · Active since 10 Dec 2025

Frequently asked questions

What is the enterprise number of QBIC Brussels Fund?
The enterprise number of QBIC Brussels Fund is BE0846785551.
What is the address of QBIC Brussels Fund?
The registered office of QBIC Brussels Fund is located at Witte Patersstraat 4, 1040 Etterbeek.
When was QBIC Brussels Fund founded?
QBIC Brussels Fund was founded on 22 June 2012.
Does QBIC Brussels Fund have a website?
No website is currently known for QBIC Brussels Fund.
How much profit did QBIC Brussels Fund make in 2025?
QBIC Brussels Fund recorded a loss after taxes of € 13,560 in financial year 2025.
What is the revenue of QBIC Brussels Fund?
As a small company, QBIC Brussels Fund is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -11,963.
How many employees does QBIC Brussels Fund have?
According to the 2025 annual accounts, QBIC Brussels Fund has 0 full-time equivalents (FTE).
Where can I find the annual accounts of QBIC Brussels Fund?
QBIC Brussels Fund files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of QBIC Brussels Fund?
According to the 2025 annual accounts, the directors of QBIC Brussels Fund are: Qbic Venture Partners BV, Jan Cornelis, Finance&invest.brussels NV, ING België NV, Yannik Hallet, Isabelle Cardinael, BNP Paribas Fortis Private Equity Belgium NV, Jean-Pierre Timmermans.
Who owns QBIC Brussels Fund?
It owns 5.5% of Ubidata and 2.7% of Confo Therapeutics itself.